Bildkälla: Stockfoto

Lytix Biopharma: Redeye Resumes Coverage - Redeye

Through the completion of the equity issue, Lytix receives NOK50m before transaction costs. The issue was almost fully subscribed to the lower amount, with around 5% going to certain pre-committing shareholders and guarantors.

Through the completion of the equity issue, Lytix receives NOK50m before transaction costs. The issue was almost fully subscribed to the lower amount, with around 5% going to certain pre-committing shareholders and guarantors.
Börsvärldens nyhetsbrev
ANNONSER